CONMED Corporation (NYSE:CNMD) changes shares on Tuesday trading session, with a change of -0.02% or -$0.02 shares. The trading starts at $81.92 and closed at $82.41 throughout the day. The trading session low price was $80.59 and day high was $82.73 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.34 million while its average volume is 356.81K. In other hand, the CNMD market cap reached to $2.49B. While, its current target price is $98.40.
On April 29, 2020, BRIEF-Conmed Corporation Announces First Quarter 2020 Financial Results. According to the news reported on Reuters, * Q1 SALES $214 MILLION VERSUS REFINITIV IBES ESTIMATE OF $214.8 MILLION
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -0.44% and up 13.70% for month. Its quarterly performance was 22.86% above, while its half year performance is down -20.11%. CNMD yearly performance stood at negative -9.80% and fall -26.33% for year-to-date. Current recommendation for CONMED Corporation is 2.30.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. CNMD EPS (TTM) for 12-month is -0.03. EPS for this year is -29.80%, while for the next year its value is 3.06. Its EPS Q/Q reached 467.30%. It has an EPS of -3.50% down for past five years and for the next five years will be up 9.40%.
Let’s take a look on the analyst recommendations on CNMD for the current month and previous month. For the current month, 4 of 7 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 3 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $92.00 – $110.00. Average target price for CNMD was reached at $98.40.
Blackrock Inc., Vanguard Group, Inc. (The) and Capital Research Global Investors are the top three holders in CONMED Corporation (CNMD) stock. On Mar 30, 2020, Blackrock Inc. has 4.22 million shares which valued 241.5 million. On Mar 30, 2020, Vanguard Group, Inc. (The) owned 3.06 million shares which valued at 175.05 million. On Mar 30, 2020, Capital Research Global Investors has a total of 1.45 million shares which valued at 83.07 million. In the end, Capital Research Global Investors have 5.08% shares outstanding of CONMED Corporation (CNMD) on Mar 30, 2020. The insider ownership moved to 1.10%.
The company posted an EPS (TTM) of -0.03. According to the most recent quarter report on (Sep 2020), 7 analysts estimated an average EPS of 0.29, while 0.62 EPS posted a year ago period. Analyst Estimated EPS for CNMD published in the report was -$0.09 – $0.49 during the same period. Comparing with last year, the average estimated EPS was 0.62 which is higher than -0.07 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for CNMD fall -6.29% for period of 200 days. SMA for 50 days was 9.00% which is showing green signal, while SMA-20 was 4.10%. The moving average value for CONMED Corporation (CNMD) is 1.32M and 5.57% for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in CNMD stock. On Jul 31, JONAS DANIEL, EVP Legal Affairs,Gen. Counsel, sold 4,349 trading shares at the cost of $82.66, which valued at 0.36 million. On Jul 31, SHAGORY PETER K, EVP, STRAT & CORP DEVT, sold 4,440 shares at the cost of $84.57, with total shares of 1,861. On Jun 05, Ruiz-Caban Wilfredo, EVP QA, RA and Operations, sold 9,919 shares at the cost of 82.02. After this transaction, Ruiz-Caban Wilfredo total shares reached to 3,951 which valued at 0.81 million.